|
|
Post by mssciguy on Dec 14, 2015 18:41:30 GMT -5
it's getting personal now. what's getting personal? goofy ymb and stocktwits stuff. We don't know anything, period. None of us. Except the mysteriosas from Switzerland. Good night--- enough of this crime scene |
|
|
|
Post by peppy on Dec 14, 2015 18:41:30 GMT -5
|
|
|
|
Post by ricguy on Dec 14, 2015 18:46:45 GMT -5
goofy ymb and stocktwits stuff.
We don't know anything, period. None of us. Except the mysteriosas from Switzerland. Good night--- enough of this crime scene =ALOT of the post CREATED lately by the same constant posters on here. My previous post wasn't personal but this one certainly was to some. |
|
|
|
Post by bretzyboy on Dec 14, 2015 18:48:03 GMT -5
As a former long I'm more concerned with missing a rapid run up in share price if after the first of the year Sanofi reaffirms (even through silence) their commitment, sales increase steadily and new financing is arranged. Any or all of this could spark a turnabout, which could easily double or triple the price from today in a very short time.
|
|
|
|
Post by ricguy on Dec 14, 2015 18:48:36 GMT -5
Are things really that bleak where the biggest and loudest pumper of them all starts to question this investment? Isn't name-calling ("biggest and loudest pumper") grounds for at least removal of the post? I think the problem smwill77 might of had is there are multiple posts created by op about BK for MNKD. Getting old. |
|
|
|
Post by garrett on Dec 14, 2015 18:48:45 GMT -5
Something is odd with MannKind's share price, it is acting as if it is going bankrupt. My question is: would this require a filing with the SEC if that was the case? I am not sure why bankruptcy is even mentioned. Bankruptcy (Chapter 11) is generally used to stay off creditors from attaching fixed assets and/or cash. To my knowledge, MannKind does not have these type of problems. It has adequate cash to operate for several months into the future. |
|
|
|
Post by mssciguy on Dec 14, 2015 18:59:21 GMT -5
mnholdem liane the board has degenerated, sorry if I played a role in that
|
|
|
|
Post by Chris-C on Dec 14, 2015 19:05:20 GMT -5
Something is odd with MannKind's share price, it is acting as if it is going bankrupt. My question is: would this require a filing with the SEC if that was the case? Guys what is odd about it? GS called and warned almost a year ago that the price would be going to $1 and everyone laughed and blew them off including myself. Did GS talk about bankruptcy then? Since we're on the FUD/Pump subject-Looks like the FUDSTERS Beat the Hell out of the PUMPERS on this one. But was it really FUD? hmmm starting to look like it wasn't, for now. Ricguy If I were a short I would probably cover and not be waving any victory flags right now, because the game is far from over. If, because of games played by Wall Street and/or mistakes by management, the company is not successful, so be it, as long as people with diabetes can still access the drug. Afrezza is a superior product and will become a game changer, whether under Mannkind's banner or someone elses. Good luck to you. Chris C Nota bene: This "pumper" long is not going away anytime soon. I'm in Nate Pile's camp, and I notice that as of today, he was still advising his subscribers to acquire more. One of his early calls, Celgene, once traded for less than a dollar a share (actually .95 cents in December, 1988). After splits, it now trades north of $110.00. Biotech investment is clearly not for the meek or weak handed. And as for GS, their "calls" carry all the credibility of TheStreet.com. They have been shown to be duplicitous and even a broken clock is correct twice a day. |
|
|
|
Post by mssciguy on Dec 14, 2015 19:07:50 GMT -5
Guys what is odd about it? GS called and warned almost a year ago that the price would be going to $1 and everyone laughed and blew them off including myself. Did GS talk about bankruptcy then? Since we're on the FUD/Pump subject-Looks like the FUDSTERS Beat the Hell out of the PUMPERS on this one. But was it really FUD? hmmm starting to look like it wasn't, for now. Ricguy If I were a short I would probably cover and not be waving any victory flags right now, because the game is far from over. If, because of games played by Wall Street and/or mistakes by management, the company is not successful, so be it, as long as people with diabetes can still access the drug. Afrezza is a superior product and will become a game changer, whether under Mannkind's banner or someone elses. Good luck to you. Chris C Nota bene: This "pumper" long is not going away anytime soon. I'm in Nate Pile's camp, and I notice that as of today, he was still advising his subscribers to acquire more. One of his early calls, Celgene, once traded for less than a dollar a share (actually .95 cents in December, 1988). After splits, it now trades north of $110.00. Biotech investment is clearly not for the meek or weak handed. And as for GS, their "calls" carry all the credibility of TheStreet.com. They have been shown to be duplicitous and even a broken clock is correct twice a day. "No mamby pambys" |
|
|
|
Post by compound26 on Dec 14, 2015 19:14:02 GMT -5
I just read the latest edition of Nate's Notes (dated 11 December, but published today). So the notes were very updated (have the closing price of $1.53 as of last Friday). Nate does not seem to be concerned about the financial situations of Mannkind at all. He averaged down continuously and encouraged his subscribers to average down at this moment (if they are interested). He noted that MNKD's PPS, if without shorts' action, would be around $8-12. So he attributed the current PPS mainly to shorting + tax loss selling. Of course, his discussion is much more detailed than the above. Nate has 28 years' experience investing in biotech and he started to recommend Celgene when it was at $0.44 (split adjusted price) and Celgene is currently at $108 per the notes. So his experience does give me comfort. If you do not subscribe for his newsletter, maybe you can subscribe for one month for $34 to get access to the last few months' notes to see his thoughts on Mannkind. (FYI, I am not affiliated with Nate in any way.  Just a reader of his newsletter.) |
|
|
|
Post by bthomas55ep on Dec 14, 2015 19:16:12 GMT -5
Something is odd with MannKind's share price, it is acting as if it is going bankrupt. My question is: would this require a filing with the SEC if that was the case? I am not sure why bankruptcy is even mentioned. Bankruptcy (Chapter 11) is generally used to stay off creditors from attaching fixed assets and/or cash. To my knowledge, MannKind does not have these type of problems. It has adequate cash to operate for several months into the future. That said - if a company has adequate reason to believe it will be unable to pay their creditors in the future, they may file for protection under a bankruptcy filing in order to preserve its assets. It may want to preserve its assets as much as possible while negotiating with its creditors in preparation for re-emerging from Chapter 11. It may also plan for a pre-packaged bankruptcy with a debtor in possession who may have already determined where the technology is to go (Chapter 7). In both of these cases, the current common shareholders are wiped out, but the product can go on uninterrupted and ultimately achieve the intended results. As an example, Dendreon filed for Bankruptcy with over $100 Million in the bank and performed an asset auction. While it just doesn't feel we are at that point and I don't think it will happen yet, there has been absolutely nothing to let us know that a bankruptcy couldn't happen at any time. They've already completed the necessary disclosure in their regulatory filings to provide cover if it happens. |
|
|
|
Post by james on Dec 14, 2015 19:29:00 GMT -5
I am not sure why bankruptcy is even mentioned. Bankruptcy (Chapter 11) is generally used to stay off creditors from attaching fixed assets and/or cash. To my knowledge, MannKind does not have these type of problems. It has adequate cash to operate for several months into the future. That said - if a company has adequate reason to believe it will be unable to pay their creditors in the future, they may file for protection under a bankruptcy filing in order to preserve its assets. It may want to preserve its assets as much as possible while negotiating with its creditors in preparation for re-emerging from Chapter 11. It may also plan for a pre-packaged bankruptcy with a debtor in possession who may have already determined where the technology is to go (Chapter 7). In both of these cases, the current common shareholders are wiped out, but the product can go on uninterrupted and ultimately achieve the intended results. As an example, Dendreon filed for Bankruptcy with over $100 Million in the bank and performed an asset auction. While it just doesn't feel we are at that point and I don't think it will happen yet, there has been absolutely nothing to let us know that a bankruptcy couldn't happen at any time. They've already completed the necessary disclosure in their regulatory filings to provide cover if it happens. If I have it correctly, Dendreon did have $100M in cash, but a massive $620M debt that was coming due. The company continued to loose money 4 years after approval and had limited expectations for further sales growth. |
|
|
|
Post by LosingMyBullishness on Dec 14, 2015 19:37:16 GMT -5
Interesting. Lack of news with a price dropping constantly leads to interesting threads. Bit of like mice under stress in a cage starting to eat each other ears etc.
Instead of some conspiracy theories I suggest lack of demand as people are waiting for an even better price. Would I touch MNKD shares if I were not already heavily invested. No. I would set up da trailing stop buy or buy some dirt cheap distant calls at 2.
If I were a short I would have already covered as I would fear that any good news (new TS contract, even new CEO with some credentials and some nice news as a kick start) could ruin my christmas. But probably they believe that they can control this as they think that sales will stay low.
Disc: long >10k shares at ~ $5 + options
|
|
|
|
Post by mssciguy on Dec 14, 2015 19:40:48 GMT -5
Interesting. Lack of news with a price dropping constantly leads to interesting threads. Bit of like mice under stress in a cage starting to eat each other ears etc. Instead of some conspiracy theories I suggest lack of demand as people are waiting for an even better price. Would I touch MNKD shares if I were not already heavily invested. No. I would set up da trailing stop buy or buy some dirt cheap distant calls at 2. If I were a short I would have already covered as I would fear that any good news (new TS contract, even new CEO with some credentials and some nice news as a kick start) could ruin my christmas. But probably they believe that they can control this as they think that sales will stay low. Disc: long >10k shares at ~ $5 + options they do a lot more than bite at each other's ears, especially when conditions are overcrowded. Or when Goldman S. Mouse steals their food and water. |
|
|
|
Post by mnholdem on Dec 14, 2015 20:49:30 GMT -5
mnholdem liane the board has degenerated, sorry if I played a role in that Degenerates are welcome here as long as they play by the rules...  |
|
Just a reader of his newsletter.)
